These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39388913)

  • 21. Early Effect of 0.005% Estriol Vaginal Gel on Symptoms and Signs of Vulvovaginal Atrophy.
    Lázaro-Carrasco de la Fuente J; Cuerva González M; González Rodríguez S; Delgado Marín JL; Cuevas Castillo C; Nieto Magro C
    J Menopausal Med; 2022 Aug; 28(2):60-69. PubMed ID: 36070871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women.
    Kirkengen AL; Andersen P; Gjersøe E; Johannessen GR; Johnsen N; Bodd E
    Scand J Prim Health Care; 1992 Jun; 10(2):139-42. PubMed ID: 1641524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Pueraria mirifica on vaginal artery vascularization in postmenopausal women with genitourinary syndrome of menopause.
    Warinsiriruk P; Tantitham C; Cherdshewasart W; Shobeiri SA; Manonai J
    Maturitas; 2022 Jun; 160():4-10. PubMed ID: 35550707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
    Harding C; Chadwick T; Homer T; Lecouturier J; Mossop H; Carnell S; King W; Abouhajar A; Vale L; Watson G; Forbes R; Currer S; Pickard R; Eardley I; Pearce I; Thiruchelvam N; Guerrero K; Walton K; Hussain Z; Lazarowicz H; Ali A
    Health Technol Assess; 2022 May; 26(23):1-172. PubMed ID: 35535708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.
    Torella M; Del Deo F; Grimaldi A; Iervolino SA; Pezzella M; Tammaro C; Gallo P; Rappa C; De Franciscis P; Colacurci N
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():125-128. PubMed ID: 27838537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
    Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; BSc AB; Martel C; Vaillancourt M; Balser J; Moyneur É;
    Menopause; 2018 Nov; 25(11):1339-1353. PubMed ID: 30358731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
    Delgado JL; Estevez J; Radicioni M; Loprete L; Moscoso Del Prado J; Nieto Magro C
    Climacteric; 2016 Apr; 19(2):172-80. PubMed ID: 26786399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oestriol gel on dyspareunia in postmenopausal women in 2 weeks of treatment: a pilot study.
    Cuerva MJ; González SP; Lazaro-Carrasco De La Fuente J; Lopez FJ; Nieto C
    J Obstet Gynaecol; 2022 Oct; 42(7):3397-3399. PubMed ID: 35658728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effect of noninvasive radiofrequency with vaginal estrogen and vaginal moisturizer in the treatment of vulvovaginal atrophy in postmenopausal women: a randomized clinical trial.
    Gueldini de Moraes AV; Costa-Paiva L; da Costa Machado H; Maciel TF; Mariano FV; Pedro AO
    Menopause; 2024 Apr; 31(4):288-302. PubMed ID: 38412393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.
    Eriksen B
    Am J Obstet Gynecol; 1999 May; 180(5):1072-9. PubMed ID: 10329858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review.
    Mueck AO; Ruan X; Prasauskas V; Grob P; Ortmann O
    Climacteric; 2018 Apr; 21(2):140-147. PubMed ID: 29381086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
    Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
    Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal Vitamin E for Treatment of Genitourinary Syndrome of Menopause: A Systematic Review of Randomized Controlled Trials.
    Porterfield L; Wur N; Delgado ZS; Syed F; Song A; Weller SC
    J Menopausal Med; 2022 Apr; 28(1):9-16. PubMed ID: 35534426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy.
    Jaisamrarn U; Triratanachat S; Chaikittisilpa S; Grob P; Prasauskas V; Taechakraichana N
    Climacteric; 2013 Jun; 16(3):347-55. PubMed ID: 23347400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Fractional CO
    Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
    Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause.
    Gaspar A; Brandi H; Gomez V; Luque D
    Lasers Surg Med; 2017 Feb; 49(2):160-168. PubMed ID: 27546524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Chamomile Vaginal Gel on the Sexual Function in Postmenopausal Women: A Double-Blind Randomized Controlled Trial.
    Bosak Z; Iravani M; Moghimipour E; Haghighizadeh MH; Jelodarian P
    J Sex Med; 2022 Jun; 19(6):983-994. PubMed ID: 35400624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women.
    Cruz VL; Steiner ML; Pompei LM; Strufaldi R; Fonseca FLA; Santiago LHS; Wajsfeld T; Fernandes CE
    Menopause; 2018 Jan; 25(1):21-28. PubMed ID: 28763401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.